IP Library › Assignment 023823/0012
Patent Assignment
Reel/Frame 023823/0012

Assignment of Assignor's Interest

Recorded: 2010-01-20 Pages: 3
Assignor
SILENCE THERAPEUTICS AG
Executed: 2009-12-01
Assignee
QUARK PHARMACEUTICALS, INC.
6501 DUMBARTON CIRCLE, FREMONT, CALIFORNIA, 94555
Covered Property (1)
Therapeutic Uses of Inhibitors of RTP801
Patent: 7,741,299 →
Application: 11/207,119 →
Publication: US 2006/0217329
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 5, 2005
From: FEINSTEIN, ELENA
To: QUARK BIOTECH,INC.
Reel/Frame 017315/0483 →
Assignment of Assignor's Interest Jan 22, 2007
From: QUARK BIOTECH, INC.
To: ATUGEN AG
Reel/Frame 018824/0290 →
Confirmation of Exclusive Patent License Feb 6, 2007
From: QUARK BIOTECH INC.
To: PFIZER INC.
Reel/Frame 018862/0211 →
Change of Name Dec 3, 2007
From: QUARK BIOTECH, INC.
To: QUARK PHARMACUTICALS, INC.
Reel/Frame 020206/0703 →
Change of Name Sep 15, 2008
From: ATUGEN AG (AKTIENGESELLSCHAFT)
To: SILENCE THERAPEUTICS AG (AKTIENGESELLSCHAFT)
Reel/Frame 021545/0114 →
Assignment of Assignor's Interest Jan 20, 2010
From: KAUFMANN, JORG; GIESE, KLAUS
To: SILENCE THERAPEUTICS AG
Reel/Frame 023830/0738 →